Brief: Argent Biopharma Announces Intention To Delist From London Stock Exchange
28/11/2024 23:50
Nov 29 (Reuters) - Argent BioPharma Ltd RGT.AX :
* NOTICE OF INTENTION TO DELIST FROM LONDON STOCK EXCHANGE
* DECIDED TO RETAIN ITS LISTING ON ASX
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group